Table 1.

Patients characteristics (N = 29)

Patients%
Median age (min–max)66(40–81)
Gender
 Male2276%
 Female724%
Performance status
 0724%
 11966%
 223%
 NA17%
Location
 Gastric1552%
 Small bowel828%
 Large bowel27%
 Other413%
KIT mutational status
 Exon 112276%
 Exon 9310%
 Other14%
 No KIT/PDGFR mutation310%
Number of previous lines of treatment
 2724%
 3828%
 ≥41448%
Previous treatments
 Imatinib29100%
 Sunitinib29100%
 Regorafenib1034%
 Pazopanib517%
 Masitinib414%
 Sorafenib414%
 Nilotinib310%
 Dasatinib13%
 Dovitinib13%
CDKN2A mutational status
 Homozygotous1862%
 Heterozygotous1138%